Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2015, Article ID 201726, 12 pages
http://dx.doi.org/10.1155/2015/201726
Review Article

Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy

1Department of Optometry & Vision Sciences, University of Melbourne, 4th Floor, Alice Hoy Building, 162 Monash Road, Parkville, VIC 3010, Australia
2Centre for Eye Research Australia, Level 1, 32 Gisborne Street, East Melbourne, VIC 3002, Australia
3Department of Ophthalmology, University of Melbourne, Level 1, 32 Gisborne Street, East Melbourne, VIC 3002, Australia

Received 12 June 2014; Accepted 8 September 2014

Academic Editor: Petros E. Carvounis

Copyright © 2015 Selwyn M. Prea et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Vianney Delplace, Samantha Payne, and Molly Shoichet, “Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions,” Journal of Controlled Release, 2015. View at Publisher · View at Google Scholar
  • Yu Qin, Fang-Kun Zhao, Jing Li, and Jin-Song Zhang, “Functions of long noncoding RNAs and their roles in ocular diseases,” International Eye Science, vol. 16, no. 8, pp. 1469–1473, 2016. View at Publisher · View at Google Scholar
  • Jayoung Kim, Adam C. Mirando, Aleksander S. Popel, and Jordan J. Green, “Gene delivery nanoparticles to modulate angiogenesis,” Advanced Drug Delivery Reviews, 2016. View at Publisher · View at Google Scholar
  • Afrah J. Abd, Rupinder K. Kanwar, and Jagat R. Kanwar, “Age-related macular degeneration: current therapeutics for management and promising new drug candidates,” Drug Discovery Today, 2017. View at Publisher · View at Google Scholar
  • Youn-Shen Bee, Jingxiang Zhong, Bang V. Bui, Ming-Hong Tai, Guei-Sheung Liu, Leilei Tu, Shwu-Jiuan Sheu, Hsiu-Chen Lin, Jia-Hua Tang, Jiang-Hui Wang, Selwyn M. Prea, Gregory J. Dusting, and Deng-Chyang Wu, “Gene delivery of calreticulin anti-angiogenic domain attenuates the development of choroidal neovascularization in rats,” Human Gene Therapy, vol. 28, no. 5, pp. 403–414, 2017. View at Publisher · View at Google Scholar
  • Yiming Li, Ping Zhu, Amrisha Verma, Tuhina Prasad, Hongxin Deng, Dechao Yu, and Qiuhong Li, “A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization,” Journal of Cellular and Molecular Medicine, 2017. View at Publisher · View at Google Scholar
  • Khalil Ghasemi Falavarjani, and Srinivas R. Sadda, “Hot topics in pharmacotherapy for neovascular age-related macular degeneration,” Current Pharmaceutical Design, vol. 23, no. 4, pp. 535–541, 2017. View at Publisher · View at Google Scholar
  • Tetsuya Yamamoto, Shingo Takano, Eiichi Ishikawa, Masahide Matsuda, Noriaki Sakamoto, Hiroyoshi Akutsu, and Akira Matsumura, “The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas,” International Journal of Oncology, vol. 50, no. 2, pp. 515–524, 2017. View at Publisher · View at Google Scholar
  • Jing Yang, Xuefang Hao, Qian Li, Mary Akpanyung, Abdelilah Nejjari, Agnaldo Luis Neve, Xiangkui Ren, Jintang Guo, Yakai Feng, Changcan Shi, and Wencheng Zhang, “CAGW Peptide- and PEG-Modified Gene Carrier for Selective Gene Delivery and Promotion of Angiogenesis in HUVECs in Vivo,” ACS Applied Materials & Interfaces, 2017. View at Publisher · View at Google Scholar
  • Yuanyuan Shan, Binghe Wang, and Jie Zhang, “New strategies in achieving antiangiogenic effect: Multiplex inhibitors suppressing compensatory activations of RTKs,” Medicinal Research Reviews, 2018. View at Publisher · View at Google Scholar